Current Liabilities Cambiamento Data
AbbVie USD 34.77B 2.53B 2023-09
Abbott USD 14.35B 180M 2023-06
ALKERMES USD 503.11M 15.92M 2023-09
Amgen USD 18.39B 1.44B 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Baxter International USD 6.5B 294M 2023-12
Biogen USD 3.43B 1.59B 2023-12
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Catalent USD 1.04B 498M 2023-12
Eli Lilly USD 22B 3.08B 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
J&J USD 44.37B 9.8B 2023-09
Merck USD 23.09B 300M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Perrigo USD 1.01B 48.5M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Phibro Animal Health USD 172.36M 3.64M 2023-09
Prestige Brands USD 127.44M 2.27M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Revance Therapeutics USD 82.16M 8.08M 2023-09
Roche Holding CHF 26.21B 1.03B 2023-06
United Therapeutics USD 804.4M 60.3M 2023-12
Zoetis USD 1.89B 281M 2023-12



Eli Lilly Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.